Mylan Inc.
Registered Principal Details
Business Or Interest:
Pharmaceuticals
Lobbying Interests:
All matters related to the pharmaceuticals and health care industries
CEO Name:
Heather Bresch
Vice President
Pharmaceuticals
Lobbying Interests:
All matters related to the pharmaceuticals and health care industries
CEO Name:
Heather Bresch
Vice President
Contact
BL
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 203
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
5/6/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
For
Notification Date5/6/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 139
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
2015 Wisconsin Act 35
4/29/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
Bill Text and History
2015 Wisconsin Act 35
For
Notification Date4/29/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Anything relating to generic pharmaceuticals.
Anything relating to generic pharmaceuticals.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/19/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/19/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Anything affecting the manufacture, distribution, or sale of prescription drugs and medical devices.
Development, drafting or introduction of a proposal relating to
Anything affecting the manufacture, distribution, or sale of prescription drugs and medical devices.
Anything affecting the manufacture, distribution, or sale of prescription drugs and medical devices.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/19/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/19/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2015 January - June $10,500.00 |
2015 July - December $9,000.00 |
2016 January - June $5,000.00 |
2016 July - December $6,300.00 |
Total $30,800.00 |
| Total Hours Communicating | 2015 January - June 42.00 |
2015 July - December 27.00 |
2016 January - June 11.00 |
2016 July - December 19.00 |
Total 99.00 |
| Total Hours Other | 2015 January - June 17.00 |
2015 July - December 6.00 |
2016 January - June 0.00 |
2016 July - December 2.00 |
Total 25.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 40% |
2015 July - December |
2016 January - June |
2016 July - December |
Total 19% |
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 40% |
2015 July - December |
2016 January - June |
2016 July - December |
Total 19% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Anything affecting the manufacture, distribution, or sale of prescription drugs and medical devices.
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June 10% |
2015 July - December 20% |
2016 January - June |
2016 July - December |
Total 10% |
| 2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
|---|---|---|---|---|
| 2015 January - June |
2015 July - December 20% |
2016 January - June |
2016 July - December |
Total 5% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication